Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014

Documenti analoghi

• Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)
  di: Hładij, Rafał, et al.
  Pubblicazione: (2017)
• Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension
  di: Gębka, Adam, et al.
  Pubblicazione: (2018)
• Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
  di: Rajtar-Salwa, Renata, et al.
  Pubblicazione: (2020)
• The diagnostic role of cardiac magnetic resonance used “first and last time in life” in a patient with a suspected dilated phase of hypertrophic cardiomyopathy
  di: Hładij, Rafał, et al.
  Pubblicazione: (2017)
• Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
  di: Gębka, Adam, et al.
  Pubblicazione: (2018)